lidocaine hci and dextrose

Generic: lidocaine hci and dextrose

Labeler: hf acquisition co llc, dba healthfirst
NDC Directory HUMAN PRESCRIPTION DRUG NDA Inactive Finished

Drug Facts

Product Profile

Brand Name lidocaine hci and dextrose
Generic Name lidocaine hci and dextrose
Labeler hf acquisition co llc, dba healthfirst
Dosage Form INJECTION, SOLUTION
Routes
INTRAVENOUS
Active Ingredients

dextrose monohydrate 5 g/100mL, lidocaine hydrochloride anhydrous .8 g/100mL

Manufacturer
HF Acquisition Co LLC, DBA HealthFirst

Identifiers & Regulatory

Product NDC 51662-1565
Product ID 51662-1565_c75311e3-ca6f-40de-e053-2a95a90a1bda
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category NDA
Application Number NDA019830
Listing Expiration 2026-12-31
Marketing Start 2021-07-17

Pharmacologic Class

Classes
amide local anesthetic [epc] amides [cs] antiarrhythmic [epc] local anesthesia [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 516621565
Hyphenated Format 51662-1565

Supplemental Identifiers

RxCUI
1737723
UNII
LX22YL083G EC2CNF7XFP

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name lidocaine hci and dextrose (source: ndc)
Generic Name lidocaine hci and dextrose (source: ndc)
Application Number NDA019830 (source: ndc)
Routes
INTRAVENOUS
source: ndc

Resolved Composition

Strengths
  • 5 g/100mL
  • .8 g/100mL
source: ndc
Packaging
  • 250 mL in 1 CONTAINER (51662-1565-1)
source: ndc

Packages (1)

51662-1565-1 250 mL in 1 CONTAINER (51662-1565-1)

Ingredients (2)

dextrose monohydrate (5 g/100mL) lidocaine hydrochloride anhydrous (.8 g/100mL)

Linked Drug Pages (1)

LIDOCAINE HCI AND DEXTROSE ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVENOUS"], "spl_id": "c75311e3-ca6f-40de-e053-2a95a90a1bda", "openfda": {"unii": ["LX22YL083G", "EC2CNF7XFP"], "rxcui": ["1737723"], "spl_set_id": ["c75311e3-ca6e-40de-e053-2a95a90a1bda"], "manufacturer_name": ["HF Acquisition Co LLC, DBA HealthFirst"]}, "finished": true, "packaging": [{"sample": false, "description": "250 mL in 1 CONTAINER (51662-1565-1)", "package_ndc": "51662-1565-1", "marketing_start_date": "20210717"}], "brand_name": "LIDOCAINE HCI AND DEXTROSE", "product_id": "51662-1565_c75311e3-ca6f-40de-e053-2a95a90a1bda", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Amide Local Anesthetic [EPC]", "Amides [CS]", "Antiarrhythmic [EPC]", "Local Anesthesia [PE]"], "product_ndc": "51662-1565", "generic_name": "LIDOCAINE HCI AND DEXTROSE", "labeler_name": "HF Acquisition Co LLC, DBA HealthFirst", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "LIDOCAINE HCI AND DEXTROSE", "active_ingredients": [{"name": "DEXTROSE MONOHYDRATE", "strength": "5 g/100mL"}, {"name": "LIDOCAINE HYDROCHLORIDE ANHYDROUS", "strength": ".8 g/100mL"}], "application_number": "NDA019830", "marketing_category": "NDA", "marketing_start_date": "20210717", "listing_expiration_date": "20261231"}